Drug class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
10 drugs the FDA files under Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- Abacavir and lamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor$35.70HealthWarehouse
- Abacavir, dolutegravir and lamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Dolutegravir and lamivudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- Entecavir · 2 strengths and formsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor$33.39Cost Plus Drugs
- Lamivudine · 4 strengths and formsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor$287.70HealthWarehouse
- Lamivudine and zidovudineHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor$18.61Cost Plus Drugs
Cheapest option we hold for the usual fill, fees included, checked November 4, 2026. Open a medicine for every option and the date on each one.